Qualify For a Study or Trial

The biggest obstacle in getting a celiac drug to market is recruiting enough patients to participate in clinical trials. Your participation is critical.

Take charge of your celiac disease to make better treatments and, one day, a cure for celiac disease a reality. Gain a better understanding of your celiac disease and how to manage it and potentially benefit from new medications or therapies that can improve your symptoms and your quality of life. See if you may qualify for a study or trial today!

‌

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Don’t see your state? Take a study screening survey to join the waitlist and be notified when a site becomes available near you!

Current Studies & Trials

Phase 1b Study of ANB033 for Celiac Disease 

U.S. Multi-Site

AnaptysBio is conducting a phase 1b clinical trial testing the safety, tolerability, and potential signals of efficacy of the investigational drug ANB033. ANB033 is a monoclonal antibody being studied for its potential to reduce intestinal inflammation, improve intestinal health, and alleviate symptoms caused by gluten exposure in adults living with celiac disease. 

Compensation for time and travel is available. 

Requirements:  

  • 18-70 years old 
  • Diagnosed with celiac disease by biopsy at least 12 months ago 
  • Attempting a gluten-free diet for at least 12 months 

Additional eligibility criteria will apply.  

Learn More

AVALON

U.S. Multi-Site

AVALON is a phase 1 clinical trial assessing the investigational drug VTP-1000 in adults with celiac disease.

This investigational targeted immunotherapy is designed to prevent or reduce symptoms from accidental gluten exposure by promoting tolerance to gluten.

Eligibility Criteria:

  • 18–70 years old
  • Celiac disease confirmed by biopsy within the past 20 years
  • Have been on a gluten-free diet for 12+ months
  • US resident

Additional criteria apply, and compensation for your time and travel may be available.

Learn more at avalon.celiac.org.

See If You Qualify

DAISY Study

U.S. MULTI-SITE

The DAISY Study is aiming to learn more about an investigational medication for celiac disease. Those who qualify may receive compensation for study-related travel expenses. 

You may be eligible to take part if you: 

  • are 18–75 years of age 
  • have a diagnosis of celiac disease with intestinal damage  
  • still experience symptoms of celiac disease despite attempting a gluten-free diet for at least 1 year. 

Eligible participants will receive study-related medical care at no cost. Health insurance is not required. 

See if You Qualify

It is important for patients to fully understand the potential risks and benefits of participating in a study or clinical trial and to discuss their options with their healthcare provider before making a decision. However, for many celiac patients, participation in a study or clinical trial can be a valuable and rewarding experience.

If you have questions about participating in a clinical trial or study listed here, please contact us at icureceliac@celiac.org or 844-593-8169 x121.